PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
2026-08-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Telix to Host R&D Day in New York City on September 22, 2026
2026-08-06T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
2026-08-05T    Banking/Financial Service   Biotechnology   Computer/Electronics 
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product
2026-08-05T    Biotechnology   Health Care/Hospital 
Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea
2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Everest Medicines to Announce 2026 Interim Results and Host Online Investor Call on August 19, 2026
2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026
2026-08-05T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing
2026-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
72 patient multi-indication trial approved to fast track TRP-8803 commercialisation
2026-08-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.